(
A) SARS-CoV-2 genome. The SARS-CoV-2 nsp14 exoribonuclease nucleotides and amino acid mutations (D90A/E92A) are indicated. (
B) Phase-contrast images of electroporated cells. Vero E6 cells were electroporated with SARS-CoV-2 WT or nsp14 exoribonuclease knockout mutant RNA. (
C) Plaque morphology of SARS-CoV-2 WT and nsp14 exoribonuclease knockout mutant viruses. Supernatants were harvested on day 3 post-electroporation (WT) and day 4 post-electroporation (mutant) from (
B). Plaque assay was performed in Vero E6 cells and staining with neutral red solution after 48 hr infection. (
D) RT-PCR analysis. Extracellular RNA from (
B) were harvested on day 3 (WT) and day 4 (mutant). The nsp14 region of SARS-CoV-2 was amplified by RT-PCR to confirm viral production.
Figure 6—figure supplement 4—source data 1 is the original of the agarose gel. (
E) Transient replicon of SARS-CoV-2. A
Renilla luciferase gene is inserted as a reporter and the nsp14 exoribonuclease knockout is shown as indicated. (
F) Replicon luciferase assay. Huh-7 cells were electroporated with WT or mutant replicon RNA, cells were harvested and assayed for luciferase activities at indicated timepoints.